Literature DB >> 7285883

Electroshock seizures in mice: effect on brain adenosine and its metabolites.

E Lewin, V Bleck.   

Abstract

Adenosine and its immediate metabolites, inosine and hypoxanthine, were measured in mouse brain following the induction of electroshock seizures and after a subconvulsive series of electric shocks. Electroshock seizures resulted in a marked and prolonged rise in inosine, with maximal values at 5 min. Hypoxanthine increased more slowly but reached high levels by 10 min. Adenosine was unchanged. Phenytoin and to a lesser extent phenobarbital reduced these effects. Following the subconvulsive stimulus, 15 single shocks over an interval of 5 sec, inosine increased rapidly, adenosine rose slightly, and hypoxanthine did not change. Both phenytoin and phenobarbital blocked these increases in adenosine and inosine. Early elevations in inosine may play some role in seizure generation and propagation. The high levels of inosine and hypoxanthine found after recovery may be involved in the termination of epileptic activity, possibly by interacting with the benzodiazepine receptor for which they are ligands.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285883     DOI: 10.1111/j.1528-1157.1981.tb04129.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

2.  Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult.

Authors:  Victor Camera Pimentel; Maria Beatriz Moretto; Mariana Colino Oliveira; Daniela Zanini; Ana Maria Sebastião; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2015-02-27       Impact factor: 3.396

Review 3.  The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders.

Authors:  Dietrich van Calker; Knut Biber
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

4.  The anticonvulsant BW534U87 depresses epileptiform activity in rat hippocampal slices by an adenosine-dependent mechanism and through inhibition of voltage-gated Na+ channels.

Authors:  J R Dupere; T J Dale; S J Starkey; X Xie
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 5.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

6.  Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling.

Authors:  Ahmed-Ramadan Sadek; Gillian E Knight; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-06-22       Impact factor: 3.765

7.  Nitric oxide synthesis, epileptic seizures and kindling.

Authors:  L J Herberg; A Grottick; I C Rose
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

8.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.